Buyback Spend for Eli Lilly (LLY)
Buyback Spend for Eli Lilly (LLY): headline value $4.11B · YoY +64.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingBuyback SpendSwitch metric
Latest period
$4.11B
YoY change
+64.3%
5Y CAGR
+52.4%
Peak year (2019)
$4.40B
Latest annual
$4.11B
Buyback Spend history chart for Eli Lilly (LLY) from 1989 to 2025
Buyback Spend history table for Eli Lilly (LLY) from 1989 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $4.11B | +64.3% | ||
| 2024 | $2.50B | +233.3% | ||
| 2023 | $750.00M | -50.0% | ||
| 2022 | $1.50B | +20.0% | ||
| 2021 | $1.25B | +150.0% | ||
| 2020 | $500.00M | -88.6% | ||
| 2019 | $4.40B | +6.0% | ||
| 2018 | $4.15B | +1284.5% | ||
| 2017 | $299.80M | -50.0% | ||
| 2016 | $600.10M | -19.9% | ||
| 2015 | $749.50M | -6.3% | ||
| 2014 | $800.00M | -52.9% | ||
| 2013 | $1.70B | +135.5% | ||
| 2012 | $721.10M | — | ||
| 2011 | $0 | — | ||
| 2010 | $0 | — | ||
| 2009 | $0 | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | -100.0% | ||
| 2006 | $122.10M | -67.7% | ||
| 2005 | $377.90M | — | ||
| 2004 | $0 | -100.0% | ||
| 2003 | $281.10M | -27.0% | ||
| 2002 | $385.20M | -29.4% | ||
| 2001 | $545.70M | -48.2% | ||
| 2000 | $1.05B | -27.5% | ||
| 1999 | $1.45B | -33.1% | ||
| 1998 | $2.17B | +518.4% | ||
| 1997 | $351.30M | +11.7% | ||
| 1996 | $314.50M | +101.6% | ||
| 1995 | $156.00M | +40.5% | ||
| 1994 | $111.00M | +330.2% | ||
| 1993 | $25.80M | -62.3% | ||
| 1992 | $68.50M | -1.0% | ||
| 1991 | $69.20M | -93.5% | ||
| 1990 | $1.07B | +471.0% | ||
| 1989 | $186.90M | — |
Buyback Spend values are taken from Eli Lilly's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Eli Lilly (LLY) buyback spend totalled $4.11B – surged 64.3% year-over-year.
Across 2020–2025 (5 years), Eli Lilly buyback spend produced a CAGR of +52.4% – sustaining 2 straight years of year-over-year growth.
Eli Lilly buyback spend peaked at $4.40B in 2019; the latest annual figure is $4.11B in 2025 (6.6% below peak).
Across the available history, buyback spend reached its high of $4.40B in 2019 and its low of $0 in 2004.
Within Healthcare, Eli Lilly (LLY) ranks 4th among 8 peers we track. The peer median for buyback spend is $2.19B.
Eli Lilly Buyback Spend by Year
Eli Lilly Buyback Spend 2025: $4.11B
Eli Lilly buyback spend in 2025 was $4.11B, surged 64.3% from 2024.
Eli Lilly Buyback Spend 2024: $2.50B
Eli Lilly buyback spend in 2024 was $2.50B, surged 233.3% from 2023.
Eli Lilly Buyback Spend 2023: $750.00M
Eli Lilly buyback spend in 2023 was $750.00M, plunged 50.0% below 2022.
Eli Lilly Buyback Spend 2022: $1.50B
Eli Lilly buyback spend in 2022 was $1.50B, grew 20.0% from 2021.
Eli Lilly Buyback Spend 2021: $1.25B
Eli Lilly buyback spend in 2021 was $1.25B.
See more financial history for Eli Lilly (LLY).
Sector peers — Buyback Spend
Companies in the same sector as Eli Lilly, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $3.00B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Eli Lilly's buyback spend?
Latest reported buyback spend for Eli Lilly (LLY) is $4.11B (period ending December 31, 2025).
How has Eli Lilly buyback spend changed year-over-year?
Eli Lilly (LLY) buyback spend changed +64.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly buyback spend?
Eli Lilly (LLY) buyback spend compound annual growth rate is +52.4% over the most recent 5 years available.
When did Eli Lilly buyback spend hit its highest annual value?
Eli Lilly buyback spend reached its highest annual value of $4.40B in 2019.
What was Eli Lilly buyback spend in 2024?
Eli Lilly (LLY) buyback spend in 2024 was $2.50B.
What was Eli Lilly buyback spend in 2025?
Eli Lilly (LLY) buyback spend in 2025 was $4.11B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.